Found: 20
Select item for more details and to access through your institution.
Apolipoprotein E and Alzheimer's Disease.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 924, n. 1, p. 91, doi. 10.1111/j.1749-6632.2000.tb05565.x
- By:
- Publication type:
- Article
Polyglutamine Domain Proteins with Expanded Repeats Bind Neurofilament, Altering the Neurofilament Network.
- Published in:
- Annals of the New York Academy of Sciences, 1999, v. 893, n. 1, p. 192, doi. 10.1111/j.1749-6632.1999.tb07826.x
- By:
- Publication type:
- Article
APOE2 allele increased in tardive dyskinesia.
- Published in:
- Movement Disorders, 2006, v. 21, n. 4, p. 540, doi. 10.1002/mds.20768
- By:
- Publication type:
- Article
Genome-Wide Scan of Copy Number Variation in Late-Onset Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 19, n. 1, p. 69, doi. 10.3233/JAD-2010-1212
- By:
- Publication type:
- Article
Glyceraldehyde 3-Phosphate Dehydrogenase Abnormality in Metabolically Stressed Huntington Disease Fibroblasts.
- Published in:
- Developmental Neuroscience, 1998, v. 20, n. 4/5, p. 462, doi. 10.1159/000017344
- By:
- Publication type:
- Article
Pathogenesis of Inclusion Bodies in (CAG)[sub n] /Q[sub n] -Expansion Diseases with Special Reference to the Role of Tissue Transglutaminase and to Selective Vulnerability.
- Published in:
- Journal of Neurochemistry, 1999, v. 72, n. 3, p. 889, doi. 10.1046/j.1471-4159.1999.0720889.x
- By:
- Publication type:
- Article
Novel Large Apolipoprotein E-Containing Lipoproteins of Density 1.006-1.060 g/ml in Human Cerebrospinal Fluid.
- Published in:
- Journal of Neurochemistry, 1998, v. 70, n. 3, p. 1235, doi. 10.1046/j.1471-4159.1998.70031235.x
- By:
- Publication type:
- Article
Polyglutamine Domains Are Substrates of Tissue Transglutaminase: Does Transglutaminase Play a Role in Expanded CAG/Poly-Q Neurodegenerative Diseases?
- Published in:
- Journal of Neurochemistry, 1997, v. 69, n. 1, p. 431, doi. 10.1046/j.1471-4159.1997.69010431.x
- By:
- Publication type:
- Article
A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia.
- Published in:
- PLoS Genetics, 2009, v. 5, n. 2, p. 1, doi. 10.1371/journal.pgen.1000373
- By:
- Publication type:
- Article
Bathing the brain.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 3, p. 1013, doi. 10.1172/JCI68241
- By:
- Publication type:
- Article
Alzheimer’s disease: the new promise.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Alzheimer's disease: the new promise.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 4, p. 1191, doi. 10.1172/JCI62745
- By:
- Publication type:
- Article
Apolipoprotein E and brain injury: implications for children.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Apolipoprotein E and brain injury: implications for children.
- Published in:
- Developmental Medicine & Child Neurology, 2005, v. 47, n. 1, p. 64, doi. 10.1017/S0012162205000113
- By:
- Publication type:
- Article
Optimization of a Polyglutamine Aggregation Inhibitor Peptide (QBP1) Using a Thioflavin T Fluorescence Assay.
- Published in:
- Assay & Drug Development Technologies, 2007, v. 5, n. 5, p. 629, doi. 10.1089/adt.2007.083
- By:
- Publication type:
- Article
The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases.
- Published in:
- Journal of Amino Acids, 2011, p. 1, doi. 10.4061/2011/265084
- By:
- Publication type:
- Article
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.
- Published in:
- Nature Neuroscience, 2002, v. 5, n. 8, p. 731, doi. 10.1038/nn884
- By:
- Publication type:
- Article
Risky apolipoprotein in brain.
- Published in:
- Nature, 1994, v. 372, n. 6501, p. 45, doi. 10.1038/372045a0
- By:
- Publication type:
- Article
Apolipoprotein E: Emerging Story in the Pathogenesis of Alzheimer's Disease.
- Published in:
- Neuroscientist, 1995, v. 1, n. 5, p. 298, doi. 10.1177/107385849500100507
- By:
- Publication type:
- Article
Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila.
- Published in:
- Human Molecular Genetics, 2003, v. 12, n. 11, p. 1253, doi. 10.1093/hmg/ddg144
- By:
- Publication type:
- Article